Comgest Growth Europe EUR R AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 16.4 | 25.7 | -16.5 | 19.7 | 10.0 | |
+/-Cat | 1.7 | 8.9 | -0.6 | 6.3 | 3.0 | |
+/-B’mrk | 4.5 | 5.6 | -3.6 | 6.3 | 1.3 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: MSCI Europe Growth NR EUR |
Key Stats | ||
NAV 25/04/2024 | EUR 42.54 | |
Day Change | -2.07% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | IE00B6X8T619 | |
Fund Size (Mil) 25/04/2024 | EUR 6244.34 | |
Share Class Size (Mil) 25/04/2024 | EUR 77.00 | |
Max Initial Charge | 2.00% | |
Ongoing Charge 20/02/2023 | 2.05% |
Morningstar Research |
Analyst Report | 20/09/2023 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 25 |
Parent | 24 |
Process | 25 |
Performance | |
Price |
Investment Objective: Comgest Growth Europe EUR R Acc |
The investment objective of the Fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 01/11/2009 | ||
Pierre Lamelin 28/02/2022 | ||
Click here to see others | ||
Inception Date 02/04/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | MSCI Europe Growth NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe EUR R Acc | 31/12/2023 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 7.76 |
ASML Holding NV | Technology | 7.71 |
Essilorluxottica | Healthcare | 4.66 |
Accenture PLC Class A | Technology | 4.62 |
Linde PLC | Basic Materials | 4.10 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe EUR R Acc |